LP343292-1
Glecaprevir
Active
Description
Glecaprevir is a hepatitis C virus (HCV) NS3/NS4A protease inhibitor. As of 2019, it is available in the U.S. in combination with pibrentasvir, an HCV NS5A inhibitor. The combination drug has high efficacy in treating patients with chronic HCV infection for HCV genotypes 1-6 ("pangenotypic"). PMID: 30977945 Source: Regenstrief LOINC
Basic Part Properties
- Part Display Name
- Glecaprevir
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2019-04-23
- Construct for LOINC Short Name
- Glecaprevir
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP343292-1 - ConceptMap translate
- https:
//fhir.loinc.org/ConceptMap/$translate?system=http: //loinc.org&code=LP343292-1
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| zh-CN | Chinese (China) | 格卡瑞韦 Synonyms: CAS 1365970-03-1; |
| it-IT | Italian (Italy) | Glecaprevir |
| es-ES | Spanish (Spain) | Glecaprevir |
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright